What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Prantae Solutions, Prantae Solutions Private Limited, Zone B, Sector A, S-3/35, Mancheswar Industrial Estate, Bhubaneswar (2026)

04/09/2026

🪈✨𝗛𝗮𝗽𝗽𝘆 𝗞𝗿𝗶𝘀𝗵𝗻𝗮 𝗝𝗮𝗻𝗺𝗮𝘀𝗵𝘁𝗮𝗺𝗶!✨🪈

As we celebrate the birth of Lord Krishna, Prantae Solutions extends warm wishes to our employees, stakeholders, partners, and the community that makes our work possible.

Janmashtami is a celebration of joy, devotion, and togetherness, a reminder to pause, reconnect with loved ones, and give thanks for the blessings in our lives. This year, we also ask that you carry that same spirit into how you care for yourselves.

Festivities often come with long fasts, elaborate feasts, and late nights of celebration, all part of what makes the day special. We simply encourage everyone to enjoy the day mindfully: stay hydrated, pace your celebrations, and listen to your body through fasting and feasting alike.

At Prantae, health has always been at the heart of what we do, and that belief extends beyond our work in renal diagnostics to how we hope our community lives each day.

Happy Janmashtami, from all of us at Prantae Solutions.

31/08/2026

India carries the world's second-highest chronic kidney disease burden: an estimated 138 million people. The response experts are calling for isn't more dialysis capacity. It's screening the right people, before the disease progresses far enough to need it.

That's the core of what the 𝗜𝗻𝗱𝗶𝗮𝗻 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗼𝗳 𝗡𝗲𝗽𝗵𝗿𝗼𝗹𝗼𝗴𝘆 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗽𝘂𝘀𝗵𝗶𝗻𝗴: 𝗻𝗼𝘁 𝗯𝗹𝗮𝗻𝗸𝗲𝘁, 𝗽𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻-𝘄𝗶𝗱𝗲 𝘁𝗲𝘀𝘁𝗶𝗻𝗴, 𝘄𝗵𝗶𝗰𝗵 𝗺𝗼𝘀𝘁 𝗵𝗲𝗮𝗹𝘁𝗵 𝘀𝘆𝘀𝘁𝗲𝗺𝘀 𝗰𝗮𝗻'𝘁 𝘀𝘂𝘀𝘁𝗮𝗶𝗻, 𝗯𝘂𝘁 𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝘀𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝗳𝗼𝗰𝘂𝘀𝗲𝗱 𝗼𝗻 𝗴𝗿𝗼𝘂𝗽𝘀 𝗮𝗹𝗿𝗲𝗮𝗱𝘆 𝗸𝗻𝗼𝘄𝗻 𝘁𝗼 𝗰𝗮𝗿𝗿𝘆 𝗼𝘂𝘁𝘀𝗶𝘇𝗲𝗱 𝗿𝗶𝘀𝗸. Diabetics. The hypertensive. People with a family history of kidney disease. Communities in CKDu-affected regions where occupational and environmental exposure compounds the risk further.

The logic is sound, but targeted screening only works if testing can actually reach those populations repeatedly, affordably, and without requiring a trip to a centralized lab. And 𝘁𝗵𝗲 𝗽𝗮𝗿𝗮𝗺𝗲𝘁𝗲𝗿 𝘁𝗵𝗮𝘁 𝗺𝗮𝘁𝘁𝗲𝗿𝘀 𝗺𝗼𝘀𝘁 𝗳𝗼𝗿 𝗰𝗮𝘁𝗰𝗵𝗶𝗻𝗴 𝗸𝗶𝗱𝗻𝗲𝘆 𝗱𝗮𝗺𝗮𝗴𝗲 𝗲𝗮𝗿𝗹𝘆, 𝗯𝗲𝗳𝗼𝗿𝗲 𝗲𝗚𝗙𝗥 𝗱𝗲𝗰𝗹𝗶𝗻𝗲 𝗯𝗲𝗰𝗼𝗺𝗲𝘀 𝗶𝗿𝗿𝗲𝘃𝗲𝗿𝘀𝗶𝗯𝗹𝗲, 𝗶𝘀 𝘂𝗿𝗶𝗻𝗮𝗿𝘆 𝗮𝗹𝗯𝘂𝗺𝗶𝗻-𝘁𝗼-𝗰𝗿𝗲𝗮𝘁𝗶𝗻𝗶𝗻𝗲 𝗿𝗮𝘁𝗶𝗼 (𝘂𝗔𝗖𝗥), 𝗮 𝗺𝗮𝗿𝗸𝗲𝗿 𝘁𝗵𝗮𝘁 𝘀𝗵𝗼𝘄𝘀 𝘂𝗽 𝗹𝗼𝗻𝗴 𝗯𝗲𝗳𝗼𝗿𝗲 𝘀𝘆𝗺𝗽𝘁𝗼𝗺𝘀 𝗱𝗼.

This is precisely where point-of-care testing changes the equation. 𝗣𝗿𝗼𝗳𝗹𝗼-𝗨 𝗺𝗲𝗮𝘀𝘂𝗿𝗲𝘀 𝘂𝗔𝗖𝗥 𝗱𝗶𝗿𝗲𝗰𝘁𝗹𝘆 𝗮𝘁 𝘁𝗵𝗲 𝗽𝗼𝗶𝗻𝘁 𝗼𝗳 𝗰𝗮𝗿𝗲, 𝘄𝗶𝘁𝗵 𝗻𝗼 𝘀𝗮𝗺𝗽𝗹𝗲 𝘁𝗿𝗮𝗻𝘀𝗽𝗼𝗿𝘁, 𝗻𝗼 𝗹𝗮𝗯 𝘁𝘂𝗿𝗻𝗮𝗿𝗼𝘂𝗻𝗱, 𝗮𝗻𝗱 𝗻𝗼 𝗱𝗲𝗽𝗲𝗻𝗱𝗲𝗻𝗰𝘆 𝗼𝗻 𝗶𝗻𝗳𝗿𝗮𝘀𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗲 𝘁𝗵𝗮𝘁 𝗱𝗼𝗲𝘀𝗻'𝘁 𝗲𝘅𝗶𝘀𝘁 𝗶𝗻 𝗲𝘃𝗲𝗿𝘆 𝗱𝗶𝘀𝘁𝗿𝗶𝗰𝘁.

For a targeted-screening strategy to work at the population level the ISN envisions, the test has to go to the high-risk patient, not the other way around. That's the gap Proflo-U is built to close.

28/08/2026

A mandate for biannual, population-scale kidney screening is only as real as the diagnostics that can deliver it.

The Parliamentary Standing Committee's vision of mandatory kidney function testing for everyone above 20, free or near-free, delivered through the NP-NCD is ambitious in exactly the right way. But it also asks a hard question of India's diagnostic infrastructure: how do you run this kind of testing at the volume, speed, and cost the mandate implies, especially for the outdoor labourers, high-risk patients, and rural populations the committee specifically names?

This is the gap Proflo-U was built to close.

As an indigenous, point-of-care diagnostic platform, Proflo-U is designed to move kidney function assessment out of centralized labs and tertiary hospitals, and into the settings where this mandate actually has to be delivered: primary health centres, community screening camps, and the hands of frontline health workers. No long turnaround times. No dependency on infrastructure that doesn't exist in every district. Just fast, reliable, affordable testing, where and when people need it.

Policy has now caught up to what early detection requires. The work ahead for us, and for the broader diagnostics community, is making sure the technology is ready to meet that mandate at scale, so that "early diagnosis" becomes something every Indian can actually access, not just something the report recommends.

26/08/2026

Dialysis three times a week, for the rest of a life — or a test that costs almost nothing.

That is the choice India's health system has effectively been offering families for years: minimal investment in early detection, followed by catastrophic, recurring costs once kidney failure sets in. The parliamentary committee's recommendations are a direct attempt to rewrite that equation.

"...to enable early diagnosis and delay disease progression," is how the committee frames the goal of its testing mandate, and the economics behind that phrase are significant. Every case caught at an early stage, before eGFR decline becomes irreversible, is a case where costly interventions like dialysis or transplantation can potentially be delayed or avoided altogether and where the more effective the earlier care, the more the disease can be managed rather than treated as a crisis.

The committee's insistence that testing be free for BPL households and nominal cost for others is the structural piece that makes this shift possible at scale. Screening that is expensive or inconvenient doesn't happen for daily-wage workers, not for rural populations, not for people who feel fine. Affordable, accessible testing changes that calculus entirely.

This is where diagnosis stops being a privilege of proximity to a good hospital, and starts being something every primary health centre can offer. That infrastructure question how India actually delivers on this mandate is what we'll turn to next.

21/08/2026

Chronic kidney disease doesn't announce itself. It progresses for years, sometimes over a decade, while function quietly erodes underneath. "𝗖𝗞𝗗 𝗿𝗲𝗺𝗮𝗶𝗻𝘀 𝗹𝗮𝗿𝗴𝗲𝗹𝘆 𝗮𝘀𝘆𝗺𝗽𝘁𝗼𝗺𝗮𝘁𝗶𝗰 𝗱𝘂𝗿𝗶𝗻𝗴 𝗶𝘁𝘀 𝗲𝗮𝗿𝗹𝘆 𝘀𝘁𝗮𝗴𝗲𝘀 𝗮𝗻𝗱 𝗶𝘀 𝘁𝗵𝗲𝗿𝗲𝗳𝗼𝗿𝗲 𝗳𝗿𝗲𝗾𝘂𝗲𝗻𝘁𝗹𝘆 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗲𝗱 𝗼𝗻𝗹𝘆 𝗮𝗳𝘁𝗲𝗿 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁 𝗮𝗻𝗱 𝗶𝗿𝗿𝗲𝘃𝗲𝗿𝘀𝗶𝗯𝗹𝗲 𝗹𝗼𝘀𝘀 𝗼𝗳 𝗸𝗶𝗱𝗻𝗲𝘆 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻 𝗵𝗮𝘀 𝗼𝗰𝗰𝘂𝗿𝗿𝗲𝗱," the Parliamentary Standing Committee on Health and Family Welfare, chaired by Rajya Sabha MP Ram Gopal Yadav, noted in its report.

That single sentence explains why the panel's recommendations matter so much to clinicians and health systems, not just policymakers. 𝗪𝗶𝘁𝗵 𝗮 𝗽𝗼𝗼𝗹𝗲𝗱 𝗖𝗞𝗗 𝗽𝗿𝗲𝘃𝗮𝗹𝗲𝗻𝗰𝗲 𝗼𝗳 𝗿𝗼𝘂𝗴𝗵𝗹𝘆 𝟭𝟯.𝟮𝟰% 𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹𝗹𝘆, the disease burden is not a rare-case problem; it's a population-level one hiding in plain sight.

The report names the populations carrying the highest risk with real precision: people with diabetes or hypertension, adults over 60, those with a family history of kidney disease, to***co users, people with excess weight, prior kidney injury, recurrent urinary infections or kidney stones, and long-term users of NSAIDs or other kidney-affecting medicines. It also flags a geography-specific risk often missing from national conversations: farm workers and outdoor labourers in regions linked to Chronic Kidney Disease of Unknown Etiology, specifically parts of Andhra Pradesh, Odisha, and Karnataka, where heat stress, repeated dehydration, and agrochemical exposure are suspected contributors.

For nephrologists, primary care physicians, and public health workers, this is a mandate to build screening pathways that specifically reach these groups.

19/08/2026

We are delighted to welcome 𝗠𝗿. 𝗣. 𝗣𝗿𝗮𝗱𝗲𝗲𝗽 𝘁𝗼 𝗣𝗿𝗮𝗻𝘁𝗮𝗲 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗮𝘀 𝗼𝘂𝗿 𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗦𝗮𝗹𝗲𝘀 𝗛𝗲𝗮𝗱.

With 20 years of experience in the pharmaceutical and healthcare industry, Pradeep brings a proven track record of driving business growth, building high-performing teams, and leading successful market expansion initiatives across South and West India. 𝗛𝗶𝘀 𝗰𝗮𝗿𝗲𝗲𝗿 spans 𝗹𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽 𝗿𝗼𝗹𝗲𝘀 𝗮𝘁 renowned organizations including 𝗕𝗼𝗲𝗵𝗿𝗶𝗻𝗴𝗲𝗿 𝗜𝗻𝗴𝗲𝗹𝗵𝗲𝗶𝗺, 𝗗𝗿. 𝗥𝗲𝗱𝗱𝘆’𝘀 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝗶𝗲𝘀, 𝗥𝗮𝗻𝗯𝗮𝘅𝘆 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝗶𝗲𝘀, 𝗮𝗻𝗱 𝗧𝗮𝗯 𝗣𝗮𝗰𝗸 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀, where he consistently delivered outstanding sales performance and organizational growth.

He has successfully launched and scaled key healthcare brands, led large cross-functional teams, expanded market presence across multiple states, and consistently achieved or exceeded business targets.

At Prantae Solutions, Mr. Pradeep will play a pivotal role in strengthening our regional sales network, expanding market reach, building strategic customer relationships, and accelerating the adoption of our innovative diagnostic solutions across healthcare institutions and channels.

Please join us in 𝗲𝘅𝘁𝗲𝗻𝗱𝗶𝗻𝗴 𝗮 𝘄𝗮𝗿𝗺 𝘄𝗲𝗹𝗰𝗼𝗺𝗲 𝘁𝗼 𝗠𝗿. 𝗣𝗿𝗮𝗱𝗲𝗲𝗽 as we embark on an exciting journey of growth and impact together.

18/08/2026

A parliamentary committee just told India to test its kidneys twice a year.

In its 177th report, the Parliamentary Standing Committee on 𝗛𝗲𝗮𝗹𝘁𝗵 𝗮𝗻𝗱 𝗙𝗮𝗺𝗶𝗹𝘆 𝗪𝗲𝗹𝗳𝗮𝗿𝗲, 𝗰𝗵𝗮𝗶𝗿𝗲𝗱 𝗯𝘆 𝗥𝗮𝗷𝘆𝗮 𝗦𝗮𝗯𝗵𝗮 𝗠𝗣 𝗥𝗮𝗺 𝗚𝗼𝗽𝗮𝗹 𝗬𝗮𝗱𝗮𝘃, has 𝗿𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗲𝗱 𝗺𝗮𝗻𝗱𝗮𝘁𝗼𝗿𝘆 𝗸𝗶𝗱𝗻𝗲𝘆 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻 𝘁𝗲𝘀𝘁𝘀 𝗲𝘃𝗲𝗿𝘆 𝘀𝗶𝘅 𝗺𝗼𝗻𝘁𝗵𝘀 𝗳𝗼𝗿 𝗲𝘃𝗲𝗿𝘆𝗼𝗻𝗲 𝗮𝗴𝗲𝗱 𝟮𝟬 𝗮𝗻𝗱 𝗮𝗯𝗼𝘃𝗲, 𝗮𝗹𝗼𝗻𝗴𝘀𝗶𝗱𝗲 𝗮𝗻𝗻𝘂𝗮𝗹 𝘀𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝗳𝗼𝗿 𝗵𝗶𝗴𝗵-𝗿𝗶𝘀𝗸 𝗶𝗻𝗱𝗶𝘃𝗶𝗱𝘂𝗮𝗹𝘀. The screening protocol itself is specific: 𝗮𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 𝗼𝗳 𝗸𝗶𝗱𝗻𝗲𝘆 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗲𝘀𝘁𝗶𝗺𝗮𝘁𝗲𝗱 𝗴𝗹𝗼𝗺𝗲𝗿𝘂𝗹𝗮𝗿 𝗳𝗶𝗹𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗿𝗮𝘁𝗲 (𝗲𝗚𝗙𝗥) 𝗮𝗻𝗱 𝘂𝗿𝗶𝗻𝗲 𝗮𝗹𝗯𝘂𝗺𝗶𝗻/𝗽𝗿𝗼𝘁𝗲𝗶𝗻 𝘁𝗲𝘀𝘁𝗶𝗻𝗴, with structured referral and follow-up.

Perhaps the most consequential line in the report is the cost mandate: 𝘁𝗲𝘀𝘁𝗶𝗻𝗴 𝘀𝗵𝗼𝘂𝗹𝗱 𝗯𝗲 𝗳𝗿𝗲𝗲 𝗳𝗼𝗿 𝘁𝗵𝗼𝘀𝗲 𝗯𝗲𝗹𝗼𝘄 𝘁𝗵𝗲 𝗽𝗼𝘃𝗲𝗿𝘁𝘆 𝗹𝗶𝗻𝗲, 𝗮𝗻𝗱 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗮𝘁 𝗻𝗼𝗺𝗶𝗻𝗮𝗹 𝗰𝗼𝘀𝘁 𝗳𝗼𝗿 𝗲𝘃𝗲𝗿𝘆𝗼𝗻𝗲 𝗲𝗹𝘀𝗲, under the National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD).

The report titled "𝗣𝗿𝗲𝘃𝗮𝗹𝗲𝗻𝗰𝗲 𝗼𝗳 𝗖𝗵𝗿𝗼𝗻𝗶𝗰 𝗞𝗶𝗱𝗻𝗲𝘆 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗶𝗻 𝗜𝗻𝗱𝗶𝗮: 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻, 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀, 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁" 𝗰𝗼𝗻𝘁𝗮𝗶𝗻𝘀 𝟲𝟲 𝗿𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗮𝘁𝗶𝗼𝗻𝘀 𝘀𝗽𝗮𝗻𝗻𝗶𝗻𝗴 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻, 𝗲𝗮𝗿𝗹𝘆 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻, 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀, 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁, 𝗮𝗻𝗱 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗼𝗳 𝗖𝗞𝗗, including strengthening nephrology services at district hospitals and a dedicated national programme for paediatric kidney care.

This is a genuine policy pivot from reacting to kidney failure to preventing it. Over the next few weeks, we'll be unpacking what it means: for the renal healthcare community, for the millions living with undiagnosed CKD, and for how India builds the diagnostic infrastructure to actually deliver on it.

18/08/2026

We are extremely delighted to welcome 𝗠𝗿. 𝗩𝗶𝘃𝗲𝗸 𝗞𝘂𝗺𝗮𝗿 to Prantae Solutions as our 𝗛𝗲𝗮𝗱 𝗼𝗳 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁.

With over two decades of experience in government healthcare and MedTech markets, Vivek brings deep expertise in public healthcare systems, government procurement, market access, strategic partnerships, and large-scale healthcare program implementation. Throughout his career, he has successfully worked with national health missions, state health departments, NGOs, corporates, and ministerial organizations, helping organizations establish and expand their presence across government healthcare channels.

His leadership journey includes key roles across renowned healthcare and diagnostics organizations, where he spearheaded government business initiatives, secured strategic healthcare projects, expanded product adoption, and built strong stakeholder networks across India.

Mr. Vivek's deep knowledge of the government ecosystem will be crucial in strengthening our institutional partnerships and accelerating market expansion. It will also promote the adoption of our solutions in public healthcare programs nationwide as Prantae Solutions continues its mission to provide cutting-edge diagnostic technologies to enhance healthcare accessibility.

Please join us in extending a warm welcome to Vivek as we embark on this exciting new chapter of growth and impact.

15/08/2026

Celebrating 80 Years of Freedom, Resilience, and Innovation 🇮🇳

On this 80th Independence Day, Prantae Solutions salutes the brave freedom fighters who paved the path to a free India through courage, sacrifice, and unwavering vision.

As an indigenous Indian start-up, we draw daily inspiration from our nation's rich legacy of resilience. We are proud to contribute to India’s journey toward self-reliance (Atmanirbhar Bharat) by driving healthcare innovation through homegrown diagnostics.

To our incredible employees, consumers, stakeholders, and partners, thank you for being an integral part of our journey. Your trust and dedication empower us to innovate, grow, and take proud Indian technology to the world.

Let us celebrate how far we’ve come and continue building a stronger, healthier, and vibrant India together!

Wishing you all a very Happy 80th Independence Day! 🇮🇳✨

12/08/2026

What happens to the women who survive preeclampsia?

Most patients assume the answer is “they recover”. Blood pressure returns to normal. Proteinuria clears. The mother and newborn come home, and people consider the difficult times to be over.
The data tells a different story.

According to multiple studies and long-term cohorts, 𝗽𝗿𝗲𝗲𝗰𝗹𝗮𝗺𝗽𝘁𝗶𝗰 𝘄𝗼𝗺𝗲𝗻 𝗳𝗮𝗰𝗲 𝘀𝗲𝘃𝗲𝗿𝗲 𝗹𝗼𝗻𝗴-𝘁𝗲𝗿𝗺 𝗿𝗶𝘀𝗸𝘀: 𝘁𝗵𝗲𝘆 𝗮𝗿𝗲 𝗳𝗶𝘃𝗲 𝘁𝗶𝗺𝗲𝘀 𝗺𝗼𝗿𝗲 𝗹𝗶𝗸𝗲𝗹𝘆 𝘁𝗼 𝗱𝗲𝘃𝗲𝗹𝗼𝗽 𝗲𝗻𝗱-𝘀𝘁𝗮𝗴𝗲 𝗸𝗶𝗱𝗻𝗲𝘆 𝗱𝗶𝘀𝗲𝗮𝘀𝗲, 𝘄𝗶𝘁𝗵 𝟭𝟵% 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗶𝗻𝗴 𝗖𝗞𝗗.

Population data show a 𝟰-𝗳𝗼𝗹𝗱 𝗿𝗶𝘀𝗲 𝗶𝗻 𝗺𝗶𝗰𝗿𝗼𝗮𝗹𝗯𝘂𝗺𝗶𝗻𝘂𝗿𝗶𝗮 𝗮𝘁 𝟳 𝘆𝗲𝗮𝗿𝘀 𝗽𝗼𝘀𝘁𝗽𝗮𝗿𝘁𝘂𝗺, which increases to an 8-fold increase if preeclampsia was severe. The damage does not reverse at delivery. Most women do not suspect it, but 𝘁𝗵𝗲 𝗱𝗮𝗺𝗮𝗴𝗲 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀𝗲𝘀 𝘀𝗶𝗹𝗲𝗻𝘁𝗹𝘆, 𝗼𝘃𝗲𝗿 𝘁𝗵𝗲 𝘆𝗲𝗮𝗿𝘀 till it cannot be ignored.

The question we need to ask, as clinicians, hospital systems, and public health policymakers, is not just "how do we detect preeclampsia earlier?" It is: "how can we help the women to survive it, beyond childbirth?"

What clinicians can do:
• Screen for microalbuminuria at the 6-week postpartum visit and annually thereafter
• Flag preeclampsia history in the patient's primary care record
• Counsel every patient before discharge: her pregnancy complication is a lifelong cardiovascular and renal risk marker
• Refer to nephrology if albuminuria persists beyond 12 weeks postpartum

The KDIGO guidelines recommend post-preeclampsia kidney monitoring. 𝗔 𝘂𝗿𝗶𝗻𝗲 𝗺𝗶𝗰𝗿𝗼𝗮𝗹𝗯𝘂𝗺𝗶𝗻 𝘁𝗲𝘀𝘁, 𝗼𝗻𝗰𝗲 𝗮 𝘆𝗲𝗮𝗿, 𝗳𝗼𝗿 𝗲𝘃𝗲𝗿𝘆 𝘄𝗼𝗺𝗮𝗻 𝘄𝗶𝘁𝗵 𝗮 𝗵𝗶𝘀𝘁𝗼𝗿𝘆 𝗼𝗳 𝗽𝗿𝗲𝗲𝗰𝗹𝗮𝗺𝗽𝘀𝗶𝗮, is the only clinical tool sensitive enough to catch this pipeline before it becomes irreversible.

After delivery, women who had preeclampsia, particularly those with persistent hypertension, symptomatic proteinuria, or microalbuminuria, should receive regular check-ups for kidney disease.

Prantae Solutions

04/09/2026

31/08/2026

28/08/2026

26/08/2026

21/08/2026

19/08/2026

18/08/2026

18/08/2026

15/08/2026

12/08/2026

Address

Opening Hours

Telephone

Website

Alerts

Contact The Practice

Shortcuts

Share

Category

Listing takedown request

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm